Formats
  1. Journal Article (66950)
  2. Meeting Abstract (33621)
  3. Book Section (5116)
  4. Review (3791)
  5. Editorial (2196)
  6. Conference Paper (1530)
  7. Correspondence (670)
  8. Guidelines (668)
  9. Research Letter (554)
  10. Book Whole (345)
  11. Miscellaneous (340)
Groups
  1. Department of Medicine (39130)
  2. GSK Faculty (22504)
  3. Solid Tumor Oncology Division (22118)
  4. Surgery (21312)
  5. Survivorship Research (15796)
  6. Sloan Kettering Institute Faculty (15666)

More Groups

People
  1. Marc Ladanyi (1329)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1053)

More People

Years
  1. 2026 (1)
  2. 2025 (2313)
  3. 2024 (5382)
  4. 2023 (5808)
  5. 2022 (6169)
  6. 2021 (5720)

More Years

Publications
  1. Journal of Clinical Oncology (8596)
  2. Blood (4954)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2614)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13867)
  2. American Society of Clinical Oncology (9180)
  3. Springer (7201)
  4. Nature Publishing Group (6392)
  5. American Association for Cancer Research (6014)
  6. Elsevier Science, Inc. (5526)

More Publishers

Results (115781)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS
    Meeting Abstract

    Mansoor, W.; Arkenau, H. T.; Alsina, M.; Shitara, K.; Tejani, M. A.; Thuss-Patience, P. C.; Cuffe, S.; Dvorkin, M.; Park, D.; Ando, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Acupuncture versus cognitive behavioral therapy for cognitive impairment in cancer survivors with insomnia: Implications for personalized medicine
    Meeting Abstract

    Mao, J. J.; Liou, K.; Root, J.; Li, Q. S.; Bao, T.; Garland, S. N.; Ahles, T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Evaluating gender as a predictive marker for response to bevacizuamb (Bev) in metastatic colorectal carcinoma (mCRC): Pooled analysis of 3369 patients (pts) in the ARCAD database
    Meeting Abstract

    Margalit, O.; Harmsen, W. S.; Shacham-Shmueli, E.; Petersen, M.; Boursi, B.; Saltz, L. B.; Adams, R.; Maughan, T.; Douillard, J. Y.; Van Cutsem, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to immune checkpoint inhibition and survival in BRCA-associated recurrent ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Boland, J. L.; Cadoo, K. A.; Friedman, C. F.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Durability of complete response (CR) with atezolizumab (atezo) in locally advanced/metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Loriot, Y.; Balar, A. V.; Dreicer, R.; Hoffman-Censits, J. H.; Perez-Gracia, J. L.; Petrylak, D. P.; Van der Heijden, M. S.; Shen, X.; Zhu, Q.; Ding, B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical significance of circulating tumor cells (CTCs) in hormone receptor-positive (HR+) metastatic breast cancer (MBC) patients (pts) receiving letrozole (Let) or Let plus bevacizumab (Bev): CALGB 40503 (Alliance)
    Meeting Abstract

    Magbanua, M. J. M.; Savenkov, O. O.; Asmus, E.; Ballman, K. V.; Scott, J. H.; Park, J.; Dickler, M. N.; Partridge, A. H.; Carey, L. A.; Winer, E. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase 3 trial evaluating efficacy and safety of lenvatinib in combination with pembrolizumab in patients with advanced endometrial cancer
    Meeting Abstract

    Makker, V.; Herraez, A. C.; Aghajanian, C.; Fujiwara, K.; Pignata, S.; Penson, R. T.; Dutcus, C. E.; Guo, M.; Dutta, L.; Orlowski, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 trial of Lu-177-DOTATATE in inoperable pheochromocytoma/paraganglioma
    Meeting Abstract

    Lin, F.; Del Rivero, J.; Carrasquillo, J. A.; Jha, A.; Gonzales, M. K.; Lindenberg, L.; Turkbey, B.; Lin, E.; Mena, E.; Millo, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of platinum-pemetrexed combination chemotherapy in ALK+ non-small cell lung cancer refractory to second-generation ALK TKIs
    Meeting Abstract

    Lin, J. J.; Schoenfeld, A. J.; Zhu, V. W.; Yeap, B. Y.; Chin, E.; Rooney, M.; Plodkowski, A. J.; Digumarthy, S.; Dagogo-Jack, I.; Gainor, J. F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save